REPL vs TXN
Replimune Group Inc (REPL) versus Texas Instruments Incorporated (TXN) — a side-by-side from cached financials, not a winner call.
Replimune Group Inc (REPL) is a biotechnology company listed on NASDAQ.
Texas Instruments Incorporated (TXN) is a semiconductors company listed on NASDAQ.
REPL does not have a complete income-statement cache yet.
Latest reported TXN revenue for 2025-12-31 was $17.68B. Net income was $5.00B. Revenue was up 13.0% from 2024-12-31 to 2025-12-31. TXN currently screens at market cap $274.74B and trailing P/E 51.7.
REPL currently screens at market cap $825.7M. TXN currently screens at market cap $274.74B and trailing P/E 51.7.
Not investment advice. Open the REPL and TXN stock pages for the full models.
Not investment advice.